Teneobio Announces US FDA Approval of the Investigational New Drug Application for TNB-383B and the Initiation of Phase I Clinical Studies in Multiple Myeloma Patients
29 avr. 2019 08h00 HE
|
TeneoBio, Inc
NEWARK, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Teneobio, Inc. and its affiliate TeneoOne, Inc. announced today that their investigational new drug application (IND) for TNB-383B, a bispecific...
Pharmacovigilance Market will register 10.7% CAGR to cross $8.0 billion by 2024: Global Market Insights, Inc.
25 sept. 2018 07h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Global Pharmacovigilance Market will surpass USD 8.0 billion by 2024; according to a new research report by Global Market Insights, Inc....
Altasciences établit une alliance stratégique avec Altreos Research Partners
23 mai 2018 12h17 HE
|
Altasciences Clinical Research - Canada
OVERLAND PARK, Kan., 23 mai 2018 (GLOBE NEWSWIRE) -- Vince & Associates Recherche Clinique, une société d’Altasciences, a annoncé aujourd’hui leur alliance stratégique avec Altreos Research...
Altasciences Establishes Strategic Alliance with Altreos Research Partners
23 mai 2018 12h17 HE
|
Altasciences Clinical Research - Canada
OVERLAND PARK, Kan., May 23, 2018 (GLOBE NEWSWIRE) -- Vince & Associates Clinical Research, an Altasciences company, announced today their strategic alliance with Altreos Research Partners. This...
Pharmacovigilance Market will secure 10% CAGR to cross $8 billion by 2024: Global Market Insights, Inc.
19 mars 2018 07h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, March 19, 2018 (GLOBE NEWSWIRE) -- Global Pharmacovigilance Market is set to exceed USD 8 billion by 2024; according to a new research report by Global Market Insights....
WOWIO, INC. Acquires Land to be developed into low cost housing in Northern California
09 nov. 2017 06h30 HE
|
Wowio, Inc.
WOWIO Continues to Build its base of new Businesses Henderson, NV, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Wowio, Inc. (OTC Pink: WWIO) “WWIO or The Company” has entered into an agreement for its wholly...
ISR's Contract Research Quality Benchmarking Reports Are Now Available
15 mars 2016 10h30 HE
|
Industry Standard Research
CARY, NC--(Marketwired - March 15, 2016) - Industry Standard Research (ISR) today announced the release of its annual CRO Quality Benchmarking series of reports. These three reports outline in...
ISR Projects Continued Growth Propelling the CRO Market Forward
02 févr. 2016 11h56 HE
|
Industry Standard Research
CARY, NC--(Marketwired - February 02, 2016) - Industry Standard Research (ISR) today announced a new addition to its Market Analysis suite of reports. The "2016 Edition of the CRO Market Size...
![VG Life Sciences Logo](/news-release/logo/302688/0/302688.jpg?lastModified=12%2F10%2F2016%2002%3A46%3A09&size=2)
VG Life Sciences Inc. Progress Update Phase I Cancer Study
04 sept. 2014 08h07 HE
|
VG Life Sciences
SANTA BARBARA, Calif., Sept. 4, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, (OTC Pink: VGLS) a biotechnology company, announces today an update to its physician-initiated IND phase I study to test...
ISR Reports Study Finds SGS Life Sciences a Stand-Out Phase I Service Provider
11 juin 2014 12h41 HE
|
Industry Standard Research
CARY, NC--(Marketwired - Jun 11, 2014) - Industry Standard Research (ISR) today announced the release of their "CRO Quality Benchmarking - Phase I Service Providers" report. This research,...